United States Healthcare Equipment & Supplies

Integra Lifesciences Holdings Corp (IART)

Track

The most recent insider trading activity occurred on November 5, 2025, with a reported BUY transaction by GRAVES JEFFREY A. Prior to this, significant BUY transactions were made by ESSIG STUART and HILL BARBARA B in May 2024. Several SELL transactions were also noted in late 2024 and early 2024 by various executives.
Stock chart
Ticker: IART Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GRAVES JEFFREY A
1 purchase — total 102,150 USD
Buy 5 Nov 2025
Value US$427,088.02 | Price 82.76 | Shares 23,310
Sale 3 Dec 2024
Value US$3,800,693.81 | Price 326.97 | Shares 69,388
Proposed sale 3 Dec 2024
Value US$411,550.38 | Price 288.76 | Shares 42,608
Sale 2 Dec 2024
Value US$41,063.50 | Price 24.16 | Shares 1,700
Sale 19 Aug 2024
Value US$25,700.83 | Price 21.58 | Shares 1,191
Buy 23 May 2024
Value US$1,499,978.97 | Price 28.49 | Shares 52,641
Buy 23 May 2024
Value US$1,499,978.97 | Price 28.49 | Shares 52,641
Buy 21 May 2024
Value US$995,815.52 | Price 27.40 | Shares 36,350
Sale 6 Mar 2024
Value US$305,491.72 | Price 36.59 | Shares 8,348
Proposed sale 6 Mar 2024
Value US$305,492.12 | Price 36.59 | Shares 8,348
Sale 9 Aug 2023
Value US$52,329.42 | Price 44.46 | Shares 1,177
Proposed sale 9 Aug 2023
Value US$52,329.42 | Price 44.46 | Shares 1,177
Buy 1 Jun 2023
Value US$100,035.14 | Price 37.89 | Shares 2,640
Buy 1 Jun 2023
Value US$299,985.77 | Price 38.50 | Shares 7,792
Sale 7 Mar 2023
Value US$100,064.39 | Price 54.29 | Shares 1,843
Sale 1 Mar 2023
Value US$86,463.09 | Price 55.21 | Shares 1,566
Sale 27 Feb 2023
Value US$214,730.68 | Price 57.00 | Shares 3,767
Sale 8 Dec 2022
Value US$15,684.32 | Price 56.22 | Shares 279
Sale 10 Aug 2022
Value US$65,019.58 | Price 55.81 | Shares 1,165
Sale 5 Aug 2022
Value US$446,266.40 | Price 55.78 | Shares 8,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-06 2025-11-05 B Purchase
3.1
GRAVES JEFFREY A
Non-Executive Director
23,310 +43.7%
82.76
US$427,088 		23,310 +43.7% 82.76 US$427,088
2024-12-04 2024-12-03 S Sale
2.2
Schwartz Eric

EVP, Chief Legal Officer & Sec

Officer
69,388 -5.6%
326.97
US$3,800,694 		69,388 -5.6% 326.97 US$3,800,694
2024-12-03 2024-12-03 PrS Proposed sale
2.2
Schwartz Eric

Officer

Officer
42,608
288.76
US$411,550 		42,608 288.76 US$411,550
2024-12-03 2024-12-02 S Sale
3.3
McBreen Michael J.

EVP & President, CSS

Officer
1,700 -2.9%
24.16
US$41,064 		1,700 -2.9% 24.16 US$41,064
2024-08-20 2024-08-19 S Sale
3.7
Mosebrook Jeffrey

SVP, Fin & Princ Acct Officer

Officer
1,191 -3.2%
21.58
US$25,701 		1,191 -3.2% 21.58 US$25,701
2024-05-24 2024-05-23 B Purchase
2.7
ESSIG STUART

Exec. Chairman of the Board

Executive Director
52,641 +12.1%
28.49
US$1,499,979 		52,641 +12.1% 28.49 US$1,499,979
2024-05-24 2024-05-23 B Purchase
2.7
ESSIG STUART

Exec. Chairman of the Board

Executive Director
52,641 +12.1%
28.49
US$1,499,979 		52,641 +12.1% 28.49 US$1,499,979
2024-05-22 2024-05-21 B Purchase
1.4
HILL BARBARA B
Non-Executive Director
36,350 +inf%
27.40
US$995,816 		36,350 +inf% 27.40 US$995,816
2024-03-08 2024-03-06 S Sale
3.2
DAVIS ROBERT T. JR.

EVP & President, TT

Officer
8,348 -14.3%
36.59
US$305,492 		8,348 -14.3% 36.59 US$305,492
2024-03-06 2024-03-06 PrS Proposed sale
3.2
DAVIS ROBERT T. JR.

Officer

Officer
8,348
36.59
US$305,492 		8,348 36.59 US$305,492
2023-08-10 2023-08-09 S Sale
3.7
Mosebrook Jeffrey

SVP, Fin & PAO

Officer
1,177 -4.8%
44.46
US$52,329 		1,177 -4.8% 44.46 US$52,329
2023-08-09 2023-08-09 PrS Proposed sale
3.7
Mosebrook Jeffrey

Officer

Officer
1,177
44.46
US$52,329 		1,177 44.46 US$52,329
2023-06-05 2023-06-01 B Purchase
2.2
Schwartz Eric

EVP, Chief Legal Officer & Sec

Officer
2,640 +5.7%
37.89
US$100,035 		2,640 +5.7% 37.89 US$100,035
2023-06-02 2023-06-01 B Purchase
3.1
De Witte Jan

President & CEO

Executive Director
7,792 +155.7%
38.50
US$299,986 		7,792 +155.7% 38.50 US$299,986
2023-03-08 2023-03-07 S Sale
3.3
McBreen Michael J.

EVP & President, CSS

Officer
1,843 -6.0%
54.29
US$100,064 		1,843 -6.0% 54.29 US$100,064
2023-03-03 2023-03-01 S Sale
3.2
DAVIS ROBERT T. JR.

EVP & President, TT

Officer
1,566 -3.3%
55.21
US$86,463 		1,566 -3.3% 55.21 US$86,463
2023-02-28 2023-02-27 S Sale
3.4
Evoli Lisa

EVP & CHRO

Officer
3,767 -16.8%
57.00
US$214,731 		3,767 -16.8% 57.00 US$214,731
2022-12-08 2022-12-08 S Sale
3.7
Mosebrook Jeffrey

SVP, Fin & Princ Acct Officer

Officer
279 -3.2%
56.22
US$15,684 		279 -3.2% 56.22 US$15,684
2022-08-11 2022-08-10 S Sale
3.4
Evoli Lisa

Executive Vice President &CHRO

Officer
1,165 -6.1%
55.81
US$65,020 		1,165 -6.1% 55.81 US$65,020
2022-08-08 2022-08-05 S Sale
2.9
Murphy Raymond G.
Non-Executive Director
8,000 -16.4%
55.78
US$446,266 		8,000 -16.4% 55.78 US$446,266
Explore more

More insider trading research around Integra Lifesciences Holdings Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America